Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TNO takes decisive step over IVD's (in vitro diagnostic's) but it could prove risky

This article was originally published in Clinica

Executive Summary

TNO Certification of the Netherlands has become the first testing organisation to issue CE-marking certificates for higher risk products covered by the In Vitro Diagnostics Directive (IVDD). But it could be taking a risk in doing so. The European Commission directorate responsible for medical devices told Clinica that TNO has not yet been officially notified.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074806

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel